SPAC Sponsor Spotlight: Live Oak Merchant Partners

by | Dec 13, 2021

Investment firm Live Oak Merchant Partners is one of the leading “serial” SPAC sponsors, with views of maintaining a long term presence in the asset class. Led by Rick Hendrix and Gary Wunderlich, Live Oak brings both extensive capital markets and advisory experience with an investment track record. 

Live Oak has successfully completed 2 De-SPAC transactions:

  • Live Oak I, $200M IPO. Merged with Danimer Scientific (DNMR) in Dec-2020
  • Live Oak II, $253M IPO. Merged with Navitas Semiconductor (NVTS) in Oct-2021

With two more SPACs priced and looking for a target:

  • Live Oak Mobility (LOKM), March 2021 IPO for $253M, seeking a target within the mobility and motion sectors 
  • Live Oak Crestview Climate (LOCC), in partnership with middle market PE firm Crestview, September 2021 $200M IPO, seeking a target in the climate / sustainability sectors

Rick and Gary are understandably quite bullish on the future of SPACs and the value that they can represent to both potential companies to take public, but also investors. They joined the podcast to discuss the current and future state of the market, what the public has gotten wrong, and what the industry needs to see to sustain and enhance the asset class. 

Boardroom Alpha’s SPAC Service
For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

<a href="https://www.boardroomalpha.com/author/draps/" target="_self">David Drapkin</a>

David Drapkin

Spent his formative years at Goldman Sachs and now embraces the start-up life in NYC. A long suffering Oakland (Las Vegas) Raiders fan and graduate of the Wharton School at the University of Pennsylvania. Semi-professional go-kart racer waiting for his shot.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

SPAC Research & Analysis

DA for LMAO and SeaStar Medical

Ending the week with a deal announcement for LMAO and SeaStar Medical. And the rest of the day’s news in SPACs.

Boardroom Alpha Daily Read

We take a closer look at fundamentals at baby and children’s apparel retailer Carter’s (CRI) on the heels of the company’s ESG announcement.

Boardroom Alpha Daily Read

We take a look at the day’s news, ESG trends and special situations. Mastercard (MA) ties executive bonuses to ESG goals. Ingevity (NGVT) is a discounted specialty chemicals story with an ESG twist.

Know Who Drives Return Podcast

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.